Improvements to mental health services for parents who lost a child to cancer are needed
the ONA take:
Parents of children with cancer appear to need, want, and often access bereavement mental health services after the death of their child, according to a cross-sectional study of 120 parents bereaved by cancer.
In this study, parents completed self-report assessments by phone, in person, or on their own. The parents were at 6 months to 6 years after their loss.
The study results showed 41% of bereaved parents were currently using mental health services. Talk therapy was the most commonly used service; however, 36% of parents who discontinued it reported that it was not helping.
Current use of these services was associated with more recent loss, prior mental health service use, subclinical/increased depression, insecure attachment styles, and a decreased sense of meaning.
Barriers to service use were also identified. Parents reported it was too painful to speak about their loss (64%) and too difficult to find help (60%). Minority parents were more likely to have unmet needs.
The researchers conclude that these services are needed and wanted by parents. But barriers to service use must be addressed.
In addition, high treatment dropout rates suggest the importance of developing effective grief interventions and training providers.
Parents of children with cancer appear to need, want, and often access bereavement mental health services after the death of their child.
- Clinical Trials May Benefit Oncology Patients
- Breast Cancer Overdiagnosis Also a Result of Screening Mammography Programs
- Prostate-specific PET and CT Imaging Improves Detection of Disease and Patient Care
- Cancer Risk Not Increased by Childhood Exposure to Diagnostic Radiation
- Aspirin Use May Lower Breast Cancer Risk in Women with Diabetes
- Survivorship Care Plans: Providing A Blueprint for Health Care After Cancer
- Multifaceted Role of the Nurse Navigator Includes Palliative, Supportive Care
- Cancer Recurrence Fear Reduced by Novel Psychological Intervention
- Patient Navigators Found to Boost Lung Cancer Screening Rates
- Immune Thrombocytopenia (Fact Sheet)
- Novel 3D Marker Reduces Radiation, Improves Cosmesis in Breast Conserving Surgery
- Rates at Some Milestones May Indicate Clinical Trial Results for Immunotherapeutics
- Cancer Risks for BRCA1/2 Mutation Carriers Determined by Age, Family History, Mutation Location
- Long-Term Use of TPO Receptor Agonist Safe in CLL-Associated Immune Thrombocytopenia
- Savolitinib Active, Tolerable in Subset of Advanced Papillary Renal Cell Cancer
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|